223 related articles for article (PubMed ID: 33141944)
1. Combining machine learning algorithms for prediction of antidepressant treatment response.
Kautzky A; Möller HJ; Dold M; Bartova L; Seemüller F; Laux G; Riedel M; Gaebel W; Kasper S
Acta Psychiatr Scand; 2021 Jan; 143(1):36-49. PubMed ID: 33141944
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
3. Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings.
Athreya AP; Brückl T; Binder EB; John Rush A; Biernacka J; Frye MA; Neavin D; Skime M; Monrad D; Iyer RK; Mayes T; Trivedi M; Carter RE; Wang L; Weinshilboum RM; Croarkin PE; Bobo WV
Neuropsychopharmacology; 2021 Jun; 46(7):1272-1282. PubMed ID: 33452433
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
5. Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment.
Zhou S; Ma Q; Lou Y; Lv X; Tian H; Wei J; Zhang K; Zhu G; Chen Q; Si T; Wang G; Wang X; Zhang N; Huang Y; Liu Q; Yu X
J Affect Disord; 2021 May; 287():372-379. PubMed ID: 33836365
[TBL] [Abstract][Full Text] [Related]
6. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
7. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
Nunez JJ; Nguyen TT; Zhou Y; Cao B; Ng RT; Chen J; Frey BN; Milev R; Müller DJ; Rotzinger S; Soares CN; Uher R; Kennedy SH; Lam RW
PLoS One; 2021; 16(6):e0253023. PubMed ID: 34181661
[TBL] [Abstract][Full Text] [Related]
8. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
Athreya AP; Neavin D; Carrillo-Roa T; Skime M; Biernacka J; Frye MA; Rush AJ; Wang L; Binder EB; Iyer RK; Weinshilboum RM; Bobo WV
Clin Pharmacol Ther; 2019 Oct; 106(4):855-865. PubMed ID: 31012492
[TBL] [Abstract][Full Text] [Related]
10. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
[TBL] [Abstract][Full Text] [Related]
11. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
12. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
13. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
14. [Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].
Spadone C; Sylvestre M; Chiarelli P; Richard-Berthe C
Encephale; 2005; 31(6 Pt 1):698-704. PubMed ID: 16462689
[TBL] [Abstract][Full Text] [Related]
15. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
Iosifescu DV; Nierenberg AA; Mischoulon D; Perlis RH; Papakostas GI; Ryan JL; Alpert JE; Fava M
J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
[TBL] [Abstract][Full Text] [Related]
16. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
17. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
Edwards SJ; Hamilton V; Nherera L; Trevor N
Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
[TBL] [Abstract][Full Text] [Related]
18. Early antidepressant treatment response prediction in major depression using clinical and TPH2 DNA methylation features based on machine learning approaches.
Chen B; Jiao Z; Shen T; Fan R; Chen Y; Xu Z
BMC Psychiatry; 2023 May; 23(1):299. PubMed ID: 37127594
[TBL] [Abstract][Full Text] [Related]
19. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AWF
Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
[TBL] [Abstract][Full Text] [Related]
20. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]